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Abstract
Background: The Visual Analogue Scale (VAS) and the Foot Health Status Questionnaire (FHSQ) are two commonly 
used outcome measures for evaluating foot health. This study aimed to calculate the Minimal Important Difference 
(MID) of the VAS and the FHSQ.
Methods: 184 participants with plantar heel pain were recruited from the general public to take part in two 
randomised trials (92 participants in each trial) that studied the effectiveness of two conservative interventions for 
plantar heel pain. Data from these participants were used to calculate the MIDs of the VAS and the FHSQ. An anchor-
based method was used to calculate the MIDs. Two distinct types of pain were investigated for the VAS: average pain 
and first-step pain. All four domains of the FHSQ were investigated: foot pain, foot function, footwear and general foot 
health.
Results: The MID for the VAS using the anchor-based approach was -8 mm (95% CI: -12 to -4) for average pain and -19 
mm (95% CI: -25 to -13) for first-step pain on the 100 mm VAS. The MID for the FHSQ was 13 points (95% CI: 6 to 19) for 
pain and 7 points (95% CI: 1 to 13) for function. The MID for the footwear domain of the FHSQ was -2 points (95% CI: -8 
to 4) and 0 points (95% CI: -7 to 6) for the general foot health domain of the FHSQ.
Conclusion: The results of this study provide additional evidence for MID values of the VAS and the FHSQ for plantar 
heel pain. This is important for clinicians and researchers as it provides a greater understanding of how much 
improvement is required by a patient before a minimal, worthwhile change is experienced. The calculated MIDs will 
also assist researchers with prospective sample size calculations.
Background
Health outcome assessment is an important component
of health care. Outcome measures are primarily used to
objectively detect change in a patient's health status in
response to an intervention [1]. They may also be used to
measure a patient's health status at a specific point in
time [2].
As outcome measurement has developed, there has
been a growing appreciation of the patient's perspective
of their disease and their preferences for treatment [3].
Outcome measures completed by the patient (i.e. self-
reported) are now commonly referred to as patient-
reported outcomes [4]. Patient-reported outcome mea-
sures assist clinicians' understanding of the effects of the
disease on a patient's capabilities, functioning and symp-
toms [5]; that is the effect on their health status (or
health-related quality of life).
If a significant change in health status occurs after an
intervention has been implemented a patient should be
able to perceive this change and regard it as important
[6]. Schunemann and Guyatt [7] have suggested the term
minimal important difference (MID) be used to represent
this change. The MID has been defined as "the smallest
difference in score in the domain of interest which
patients perceive as beneficial and which would mandate,
in the absence of troublesome side effects and excessive
cost, a change in the patient's management" (p. 408) [6].
The MID denotes the smallest change in health status
that is regarded as important by the patient. Accordingly,
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an important or worthwhile change in their health status
as a result of an intervention. From a research perspec-
tive, the MID is fundamental for calculating sample size
for trials in the future and can provide meaning to results
of clinical trials that have already been conducted [8].
There are many patient-reported outcome measures
that are used for conditions that affect the foot or ankle.
The Visual Analogue Scale (VAS) and the Foot Health
Status Questionnaire (FHSQ) are two such outcome mea-
sures [9,10]. Clinicians and researchers use the VAS to
measure pain severity and pain relief when an interven-
tion is implemented. The FHSQ - a more complex health
status measure - was developed to measure health-
related quality of life with respect to foot health [11]. Cur-
rently, there has only been one study that has investigated
the MID values for the VAS and the FHSQ in research
relating to foot health [12]. Although this study used an
appropriate technique (an anchor-based method), it was
not originally designed to calculate MIDs. In addition, the
study used a relatively imprecise 4-point Likert Scale to
determine which participants experience a minimally
important change. To provide greater precision when
estimating the MID, it has been suggested that a Likert
scale with up to 15-points be used [6].
Therefore, this study aimed to calculate with greater
precision the MIDs of two commonly used outcome mea-
sures for foot-related research: the Visual Analogue Scale
and the Foot Health Status Questionnaire.
Methods
Data for this study were taken from two randomised trials
evaluating conservative treatments for plantar heel pain.
Both of these trials used similar methodologies - the
same general protocol and outcome measures - which
have been reported in detail (including participant char-
acteristics) elsewhere [13,14]. Relevant data from these
trials were extracted for this study to determine the MIDs
for the VAS and the FHSQ.
Participants
Between February and June 2005, 184 participants with
plantar heel pain were recruited from the general public
to take part in two randomised trials (92 participants in
each trial). These research projects studied the effective-
ness of two conservative interventions (taping and
stretching) for plantar heel pain. Patients who had a clini-
cal diagnosis of plantar heel pain and had suffered symp-
toms for at least four weeks were invited to participate.
People were excluded if they had inflammatory, osseous,
metabolic or neurological disorders. They were also
excluded if they had received a corticosteroid injection
within the past three months, or had a known allergy to
adhesive tape if being recruited into the taping trial. Ethi-
cal approval was obtained from the relevant institutional
ethics committees and all participants gave written
informed consent to participate in the original trials.
Outcome Measures
The outcome measures were assessed after one week in
the taping trial and after two weeks in the stretching trial.
The VAS was used to measure pain levels [15,16] and the
FHSQ to measure foot health status. With respect to the
VAS, there were two different types of pain that were
being investigated: 'average pain' and 'first-step pain'.
With respect to the FHSQ, health status was measured
for all four domains: 'pain', 'function', 'footwear' and 'gen-
eral foot health' [11,17]. Both outcome measures have
undergone appropriate validation [17,18].
All the outcomes provided continuous data for each
domain on a scale of 0-100. For the VAS, the lower the
score the better (i.e. 0 = no pain and 100 = worst pain). In
contrast, for the FHSQ the higher the score the better (i.e.
100 = best foot health and 0 = worst foot health).
Calculation of the MIDs
MIDs were calculated for the VAS average pain and first-
step pain, and for the four domains of the FHSQ (pain,
function, footwear and general foot health). An anchor-
based approach was used to calculate the MIDs. The
anchor-based method has been suggested to be the most
appropriate method to determine the MID [8].
To calculate the MID using an anchor-based approach,
a 15-point Likert scale (Figure 1) was used. On the 15-
point Likert scale each number represents a different
change in health status. The numbers range from minus
seven to plus seven. Minus seven represents a change in
health status that is 'a very great deal worse', while plus
seven indicates a change that is 'a very great deal better'.
The value of zero represents 'no change' in health status.
For this project participants who answered '+2 and +3'
represented a 'small change' and participants who
answered '0 and +1' represented 'no change' in health sta-
tus. The 'no change' group on the Likert scale was repre-
sented by scores in the range of '0 to +1' on the fifteen
point Likert scale. The 'small change' (or minimal change)
group was represented by scores in the range of '+2 to+3'.
To begin the MID calculation, the mean change in both
outcome measures (VAS and FHSQ) from baseline for all
participants who answered 'no change' and 'a small
change' on the 15-point Likert scale were calculated. The
mean change on the outcome measures for the partici-
pants who answered 'no change' was then subtracted
from the mean change in outcome measure for the par-
ticipants who had experienced 'a small change' to form
the MID value (illustrated in Figure 2). This methodology
was similar to that used by Landorf and Radford [12];
however they only used a 4-point Likert scale.
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lated using Statistical Program for the Social Sciences
(SPSS) version 14.0. To assess precision of the MID esti-
mates, 95% confidence intervals were also calculated
using the statistical program Confidence Interval Analy-
sis (Version 2.0.0). As parametric statistics were reported
(e.g. mean) all outcome data were checked for normalcy
to satisfy the necessary assumptions. Variables demon-
strating a distribution that was not normal were then
assessed for outliers (i.e. participants that had scores 3
standard deviations from the mean) and those partici-
pants were removed from the analysis of that variable to
ensure a normal distribution. Three participants in the
'VAS average pain' variable and one participant in the
'FHSQ footwear' variable were removed for this reason.
Results
The MID values of the anchor-based approach for the
VAS and the FHSQ are presented in Table 1. The MID for
the VAS average pain was approximately -8 mm (95% CI:
-12 to -4) and -19 mm (95% CI: -25 to -13) for first-step
pain. The MIDs for the four domains of the FHSQ were
approximately 13 points (95% CI: 6 to 19) for pain, 7
points (95% CI: 1 to 14) for function, -2 points (95% CI: -8
to 4) for footwear and 0 points (95% CI: -7 to 6) for gen-
eral foot health.
Discussion
The VAS and the FHSQ are two outcome measures that
are commonly used in foot-related research. With respect
to plantar heel pain, the MIDs for the VAS and the FHSQ
have only been estimated once previously [12]. This pre-
vious study calculated the MID of the VAS when pain was
'at its worst' and only calculated MIDs for three domains
of the FHSQ (pain, function and general foot health). A
limitation to this study was that a relatively blunt 4-point
Likert scale method was used instead of a more precise
method (i.e. a 15-point Likert scale) to calculate the MIDs
for the VAS and the FHSQ. The present study aimed to
improve on this methodology thereby attempting to pro-
vide more precise estimates of the MIDs.
For the VAS, the MID was calculated for both average
pain and for first-step pain. Using the anchor-based
approach the MID for the VAS average pain was found to
be -8 mm (i.e. an improvement of 8 mm on the 100 mm
VAS) and -19 mm (i.e. an improvement of 19 mm on the
100 mm VAS) for first-step pain. First-step pain is the
pain experienced after a long period of non-weightbear-
ing (e.g. upon first stepping out of bed in the morning)
and is a common complaint of patients with plantar heel
pain. This indicates that on a 100 mm VAS, a reduction of
8 mm for average pain and 19 mm for first-step pain was
needed for a patient to recognise a worthwhile minimal
change in their pain level. The MID value for average pain
is comparable to our previous research that suggested a
MID value for the VAS was 9 mm for people with plantar
heel pain [12]. Interestingly, research in the emergency
medicine literature indicates that the MID for the VAS
when used in an emergency department ranges between
9 and 13 mm [19-21].
Compared to average pain, first-step pain appears to
require a greater improvement before a minimally impor-
tant change is detected by patients with plantar heel pain
(19 mm for first-step pain versus 8 mm for average pain).
This may be due to VAS scores for first-step pain being
initially much higher compared to average pain, and
therefore, a greater amount of pain relief is required to be
deemed important or worthwhile. However, such a differ-
ence has not been found when comparing severity of pain
being experienced in an emergency medicine department
[21].
With respect to the FHSQ, we found a MID of 13 points
for pain (i.e. an improvement in pain of 13 points) and 7
points for function (i.e. an improvement in function of 7
points). These are the estimated values for a minimally
important change that can be detected by patients. These
values are similar to our previous study (also determining
Figure 1 The 15-point Likert scale used in the study.
Circle only one number Statement 
7 A very great deal better 
6 A great deal better 
5 A good deal better 
4 Moderately better 
3 Somewhat better 
2 A little better 
1 About the same, hardly any better at all 
0 No change 
-1 About the same, hardly any worse at all 
-2 A little worse 
-3 Somewhat worse 
-4 Moderately worse 
-5 A good deal worse 
-6 A great deal worse 
-7 A very great deal worse 
Note: The ‘no change’ group on the Likert scale was represented by  
scores in the range of ‘0 to +1’ on the fifteen point Likert scale. The  
‘small change’ (or minimal change) group was represented by scores  
in the range of ‘+2 to+3’. 
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MID values for the pain and function domains of the
FHSQ to be 14 points for pain and 7 points for function
[12].
The current study was the first to calculate the MID for
the footwear domain of the FHSQ. The very small nega-
tive value of -2 points (i.e. a worsening) for footwear may
indicate that the four domains of the FHSQ capture dif-
ferent constructs of health status. A similar result was
found for the general foot health domain of the FHSQ
where a MID of 0 points was estimated. Therefore, this
study of participants with plantar heel pain may have
simply demonstrated that the domains of footwear and
general foot health are independent of both pain and
function, something that would appear intuitive and
which may further validate the instrument's ability to dis-
aggregate different components that contribute to health
status. However, an alternative explanation that cannot
be discounted may be that for pathology such as plantar
heel pain these sub-scales are not sensitive enough to
detect change - this issue has been raised previously for
general foot health [22]. Further research is warranted in
this area.
The results calculated in this study for the VAS and the
FHSQ may need to be used cautiously for other foot
pathologies that cause more severe levels of disability and
Figure 2 Method used to calculate the MID using the anchor-based approach.
Response
on 15 point Likert scale 
Corresponding mean change
on outcome measure 




+2 to +3 
(i.e. ‘a small change’) 
X units 
0 to +1 
(i.e. ‘no change’) 
Y units 
Notes: VAS =Visual Analogue Scale, FHSQ = Foot Health Status Questionnaire
X - Y 
Table 1: Anchor-based calculations of MID for the VAS and the FHSQ
Outcome Domain 0 to +1 +2 to +3 MID values 95% CI
Measure n = 57 n = 40
VAS Average -1.1§ -8.9† -7.8 -11.7 to -3.9
1st Step -1.9 -20.5 -18.6 -24.6 to -12.6
FHSQ Pain 8.7 21.2 12.5 5.8 to 19.2
Function 4.8 11.9 7.1 0.7 to 13.4
Footwear 1.9‡ -0.2 -2.1 -8.0 to 3.8
GFH 8.3 7.9 -0.4 -7.1 to 6.4
Abbreviations: VAS = Visual Analogue Scale, FHSQ = Foot Health Status Questionnaire, MID = Minimal Important Difference, GFH = General 
Foot Health, CI = Confidence Interval.
Note: Three variables were initially not normally distributed, so outliers that were 3SDs from the mean were removed to ensure normalcy. 
Accordingly, some variables had a lower sample size due to this, which the following symbols represent: §n = 55, ‡n = 56, †n = 39.
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For example, if a patient has severe pain and impairment
due to rheumatoid arthritis it may be reasonable to
expect that the MIDs for the FHSQ in the pain and func-
tion domains would be much larger. That is, higher initial
levels of pain and impairment in foot function may
require a greater reduction before the patient would con-
sider it to be worthwhile. As such, patients with such
pathology may have to experience more improvement
than 13 points for pain or 7 points for function on the
FHSQ - the MIDs we have calculated for plantar heel pain
- before they would consider the change worthwhile.
The MIDs calculated in this study may be used to inter-
pret results of other trials that utilise the VAS and the
FHSQ for measuring outcomes in pathology similar to
plantar heel pain. For example, if the effect of an inter-
vention is well below 13 points (e.g. a difference of 5
points) in the pain domain of the FHSQ, then the effect of
the intervention is most likely too small for patients to
detect an important change, regardless of whether the
intervention is shown to be statistically significant. This
highlights the importance when evaluating an interven-
tion in a clinical trial of considering both clinical signifi-
cance as well as statistical significance. A statistically
significant result may not always indicate that a patient
has experienced a clinically worthwhile change.
Findings from this trial may also be used to calculate
sample sizes for future trials. Prospective sample size cal-
culations are fundamental to the planning of any clinical
trial. By calculating an appropriate sample size, the study
will have sufficient statistical power to detect clinically
worthwhile changes if they do in fact exist. An under-
powered study, may lead to a Type 2 statistical error (i.e.
the study concludes that there is no difference between
the two groups, when in fact there was a clinically worth-
while difference, but the sample size was insufficient to
detect it) [23]. Similar to our previous study [12], and in
the absence of evidence to the contrary, we cautiously
suggest that our results may be used to calculate appro-
priate sample sizes for trials investigating interventions
for musculoskeletal disorders of the foot that cause a sim-
ilar level of pain and disability to plantar heel pain.
The results of this study need to be viewed in light of a
number of potential limitations. Firstly, for the anchor-
based approach the number of participants in the 'no
change' group and the 'a little change' group was 57 and
40 respectively. Larger numbers of participants in these
groups would lead to greater precision when calculating
the MID [8]. The relatively low numbers in these groups
was in part due to there being a greater amount of catego-
ries available on the 15-point Likert scale (as opposed to
the 4-point scale used in our previous study[12]). As a
result, the participants were distributed across a greater
number of categories; the end result being that the num-
ber of participants in each category was relatively less
compared to a 4-point Likert scale. Therefore, the width
of the 95% confidence intervals calculated for the MID
using the 15-point Likert scale were similar to those in
the previous study we conducted [12] that only used a 4-
point Likert scale. This resulted in no greater precision
using the 15-point Likert scale to calculate the MIDs in
this study. Accordingly, it would be beneficial in future
research to recruit a larger sample size to ensure that
there are more participants in the 'small change' and 'no
change' categories on the 15-point Likert scale.
Finally, and as discussed previously, the data used from
the two trials only assessed conservative treatments for
plantar heel pain. Therefore, the MID values may not be
able to be generalised to other pathologies and treat-
ments. Ideally, future research will investigate the MIDs
for a range of patient-reported outcome measures across
a spectrum of pathology.
Conclusion
This research project calculated the MIDs for the VAS
and the FHSQ. The results of this study provide further
evidence of the MID values for both outcome measures.
The findings will assist in interpreting results from clini-
cal trials that have used the VAS and the FHSQ as out-
come measures to evaluate an intervention's
effectiveness, particularly for plantar heel pain. Further
research would be useful to determine the MIDs for a
variety of foot pathologies that cause different levels of
pain and disability for patients. With the aforementioned
limitations in mind, researchers and clinicians can cau-
tiously use these MID values to assist in determining clin-
ically worthwhile changes in a patient's health status after
an intervention has been implemented. Finally, the MID
values are fundamental for prospective sample size calcu-
lations for clinical trials.
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